News | Cardiovascular Ultrasound | October 15, 2020

GE Healthcare Receives FDA Clearance for AI-powered Cardiovascular Ultrasound System

The Vivid Ultra Edition, AI-powered cardiovascular ultrasound system is designed to shorten diagnostic exam time and improve measurement consistency

GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

October 13, 2020 — GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

Methodical assessments of heart function are key in echocardiography but can be tedious and timeconsuming to acquire. High quality data acquisition and operator skill are key elements to achieve accurate and complete exams. And, as patients undergo subsequent monitoring exams, the reproducibility of exam assessments is key to identifying improvement or disease progression. Vivid Ultra Edition brings increased efficiencies to the scanning process for reduced exam time through up to 80% fewer clicks, 99% accuracy and less inter-operator variability. 

“We use AI Auto Measure – 2-D, AI Auto Measure – Spectrum Recognition, and Auto AFI together with Auto EF. We also use Scan Assist Pro, 4-D biplane and 4-D triplane. All of this in combination has saved us 7 to 10 minutes per scan, which is fantastic, so we really do have more time to spend with the patient,” said Rebecca Perry, Ph.D., cardiac sonography program stream coordinator, University of South Australia, in a Vivid Talk webinar.

Vivid Ultra Edition features leverage AI-driven, neural network-based algorithms designed to deliver repeatable and faster measurements in 2-D echo imaging:

• AI Auto Measure – Spectrum Recognition can semi-automatically detect the appropriate measurement of spectral Doppler images, enabling the system to fast-forward the path from scanning to measurements with 98% accuracy and 100% reproducibility. 

• AI Auto Measure – 2-D can detect the relevant points in the image used to derive key measurements of the left ventricle, performing comparable to human users with 100% reproducibility. 

• AI-based View Recognition can automatically detect with 99% accuracy and 100% reproducibility which standard 2D scan plane is acquired and store this label in the image file. Our AFI package is designed to use these data to automatically select views for strain analysis, streamlining workflow and increasing efficiency.  

“With the Vivid Ultra Edition, we offer AI capabilities that help address healthcare providers’ two key challenges in echo exams – how time consuming the exam is and the degree of variability that exists in the quantitative results,” said Dagfinn Saetre, General Manager of Cardiovascular Ultrasound at GE Healthcare. “This package supports our vision of where we need to go with cardiovascular ultrasound: tools to support less variability and improved productivity. The Vivid Ultra Edition is a solid step in our strategic roadmap.” Vivid Ultra Edition also provides uncompromised image quality and advanced visualization and navigation capabilities:

• HD Color displays anatomy and jet using shadowing, reflections and transparency to enhance the 3-D perception.

• FlexiLight offers photorealistic images to help improve visualization of moving structures and depth perception of tissues.

• 4-D TTE Pediatric probe (6VDc) provides excellent 2-D and 4-D imaging for a range of pediatric patients from neonates to teenagers.

For more information: gevividultraedition.com/3d-map


Related Content

News | Cardiac Imaging

May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on ...

Home May 12, 2026
Home
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Home April 29, 2026
Home
News | Cardiac Imaging

April 23, 2026 — Royal Philips has launched the next-generation Bridge Plus Occlusion Balloon, designed to help ...

Home April 23, 2026
Home
Feature | Cardiac Imaging | Kyle Hardner

Editor's Note: This is Part One of a three-part series highlighting several of the presentations from the American ...

Home April 23, 2026
Home
News | Cardiac Imaging

April 20, 2026 — Conavi Medical Corp. recently announced that it has received U.S. Food and Drug Administration (FDA) ...

Home April 22, 2026
Home
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Home April 01, 2026
Home
News | Cardiac Imaging

March 18, 2026 — Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 — The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
Subscribe Now